Starpharmaの収益Y / Y
Starpharmaの収益Y / Yは何ですか。
Starpharma Holdings Limitedの収益Y / Yは131.75%です。
収益Y / Yの定義は何ですか。
過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
ASXのセクタHealth Careにおける収益Y / Yの企業と比べるStarpharma
Starpharmaは何をしますか。
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Starpharmaと類似の収益y / y
- Immotion Plcの収益Y / Yは130.71%です。
- Tiscali Spaの収益Y / Yは131.08%です。
- Indiabulls Venturesの収益Y / Yは131.15%です。
- EMX Royalty Corpの収益Y / Yは131.27%です。
- Vaibhav Globalの収益Y / Yは131.41%です。
- BioXcel Therapeutics Incの収益Y / Yは131.50%です。
- Starpharmaの収益Y / Yは131.75%です。
- Peppermint Innovationの収益Y / Yは131.91%です。
- Arrowhead Pharmaceuticalsの収益Y / Yは132.20%です。
- Momentumの収益Y / Yは132.45%です。
- Upasana Financeの収益Y / Yは132.46%です。
- Quess Corpの収益Y / Yは132.54%です。
- Rhythm Pharmaceuticalsの収益Y / Yは132.57%です。